卡托普利 British Pharmacopoeia (BP) Reference Standard

Captopril An antihypertensive agent that competitively inhibits angiotensin-converting enzyme (ACE; IC&#8325;&#8320;= 23-35 nM) and acts as a reversible and competitive inhibitor of LTA4 hydrolase (IC&#8325;&#8320; = 11 &#181;M).

卡托普利 meets USP testing specifications

卡托普利

Sigma-Aldrich

Supelco

Pharmaceutical Secondary Standard; Certified Reference Material

United States Pharmacopeia (USP) Reference Standard

An antihypertensive agent that competitively inhibits angiotensin-converting enzyme (ACE; IC&#8325;&#8320;= 23-35 nM) and acts as a reversible and competitive inhibitor of LTA4</sub> hydrolase (IC&#8325;&#8320; = 11 &#181;M).

Captopril

European Pharmacopoeia (EP) Reference Standard

British Pharmacopoeia (BP) Reference Standard

卡托普利

Products

C4042

PHR1307

1091200

211875

C8856

C0430000

BP538